Support on both fronts
Destiny’s most recently acquired Phase 3-ready product, the non-toxigenic Clostridioides difficile...
Read moreSignificant milestone and trading update
RUA Life Sciences released a well-received announcement on an important milestone in the...
Read moreBuoyant jobs market, bullish outlook
UK employers are scrambling to backfill 1.1m positions displaced by the pandemic, amidst a...
Read moreBrand strength underpins strong growth outlook
UPGS’s combination of strong brands, targeted distribution channels and demonstrable success in M&A...
Read more$17m contract win for production inspection systems
Kromek announced today that it had been awarded a 7 year $17m contract with a large US OEM to...
Read morePositive momentum picking up steam
Today’s trading update from Driver Group is optimistic, highlighting a material improvement in...
Read moreStrong organic growth triggers fair value increase
AUM reached £10.8bn on 30 Sep 21, an increase of 20% in H1 (31 Mar 21: £9.0bn) and up 38% y-o-y (30...
Read moreH1 ahead of forecast and further push into sustainables
Polar has maintained its growth momentum in H1 of FY22 with AUM reaching £23.4bn on 30 Sep 21, 12%...
Read more